A.R.T. Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

A.R.T. Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,537	Closed	-$3.03M	–	1851
2019 Q2	$3.03M	Buy	30,537 +19,100	+167%	+$1.82M	0.17%	142
2019 Q1	$1.26M	Buy	11,437 +2,137	+23%	+$223K	0.08%	401
2018 Q4	$855K	Buy	+9,300	New	+$941K	0.06%	494
2018 Q1	–	Sell	-13,700	Closed	-$1.25M	–	1858
2017 Q4	$1.25M	Sell	13,700 -2,100	-13%	-$175K	0.06%	544
2017 Q3	$1.2M	Buy	+15,800	New	+$1.19M	0.06%	459
2017 Q2	–	Sell	-16,400	Closed	-$1.07M	–	1840
2017 Q1	$1.07M	Buy	+16,400	New	+$966K	0.05%	533
2016 Q3	–	Sell	-79,116	Closed	-$3.3M	–	1328
2016 Q2	$3.3M	Buy	79,116 +50,300	+175%	+$2.32M	0.16%	159
2016 Q1	$1.23M	Buy	+28,816	New	+$1.22M	0.06%	495
2015 Q2	–	Sell	-27,928	Closed	-$805K	–	1801
2015 Q1	$805K	Buy	+27,928	New	+$779K	0.03%	745

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

A.R.T. Advisors's PRAH Position: Q3 2019 in Review

A.R.T. Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 30,537 shares — an estimated $3.03M sold.

A.R.T. Advisors first reported a position in PRAH in Q1 2015 and held it in 9 quarters. The position peaked at $3.3M in Q2 2016. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

A.R.T. Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 30,537 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $3.03M.
A.R.T. Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 9 quarters.
A.R.T. Advisors's PRA Health Sciences, Inc. position peaked at $3.3M in Q2 2016.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.